Detection of ETV6 gene rearrangements in adult acute lymphoblastic leukemia

Annals of Hematology

Volumn 91, Issue 8, 2012, Pages 1235-1243

  Zhou, Min Hang ^a   Gao, Li ^a   Jing, Yu ^a   Xu, Yuan Yuan ^a   Ding, Yi ^a   Wang, Nan ^a   Wang, Wei ^a   Li, Mian Yang ^a   Han, Xiao Ping ^a   Sun, Jun Zhong ^a   Wang, Li Li ^a   Yu, Li ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Acute lymphoblastic leukemia; ETV6 gene rearrangements; Minimal residual disease; Multiplex nested RT PCR

Indexed keywords

JANUS KINASE 2; MESSENGER RNA; PROTEIN KINASE SYK; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR RUNX1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CANCER CHEMOTHERAPY; CELL LINEAGE; CONTROLLED STUDY; ETV6 ABL1 GENE; ETV6 ABL2 GENE; ETV6 GENE; ETV6 JAK2 GENE; ETV6 NCOA2 GENE; ETV6 RUNX1 GENE; ETV6 SYK GENE; FEMALE; FUSION GENE; GENE REARRANGEMENT; GENETIC ANALYSIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MNX1 ETV6 GENE; MULTIPLEX NESTED REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; PAX5 ETV6 GENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; T LYMPHOCYTE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATION; NEOPLASM, RESIDUAL; ONCOGENE PROTEINS, FUSION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; SENSITIVITY AND SPECIFICITY; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84864969242     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1431-4     Document Type: Article

References (48)

1. Pui CH, Evans WE (2006) Treatment of acute lymphoblastic leukemia. N Engl J Med 354(2):166-178 (Pubitemid 43076714)
2. Cortes JE, Kantarjian HM (1995) Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy. Cancer 76(12):2393-2417
3. Holleman A, Cheok MH, den Boer ML, Yang W, Veerman AJ, Kazemier KM, Pei D, Cheng C, Pui CH, Relling MV, Janka-Schaub GE, Pieters R, Evans WE (2004) Gene-expression patterns in drugresistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med 351(6):533-542
4. Flotho C, Coustan-Smith E, Pei D, Iwamoto S, Song G, Cheng C, Pui CH, Downing JR, Campana D (2006) Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2.Blood 108(3):1050-1057 (Pubitemid 44154644)
5. Flotho C, Coustan-Smith E, Pei D, Cheng C, Song G, Pui CH, Downing JR, Campana D (2007) A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia. Blood 110(4):1271-1277 (Pubitemid 47281425)
6. Ross ME, Zhou X, Song G, Shurtleff SA, Girtman K, Williams WK, Liu HC, Mahfouz R, Raimondi SC, Lenny N, Patel A, Downing JR (2003) Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 102(8):2951-2959 (Pubitemid 37248870)
7. Cario G, Stanulla M, Fine BM, Teuffel O, Neuhoff NV, Schrauder A, Flohr T, Schafer BW, Bartram CR, Welte K, Schlegelberger B, Schrappe M (2005) Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia. Blood 105(2):821-826 (Pubitemid 40070770)
8. Bhojwani D, Kang H, Menezes RX, Yang W, Sather H, Moskowitz NP, Min DJ, Potter JW, Harvey R, Hunger SP, Seibel N, Raetz EA, Pieters R, Horstmann MA, Relling MV, den Boer ML, Willman CL, Carroll WL (2008) Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: a Children's Oncology Group study [corrected]. J Clin Oncol 26(27):4376-4384
9. Lugthart S, Cheok MH, den Boer ML, Yang W, Holleman A, Cheng C, Pui CH, Relling MV, Janka-Schaub GE, Pieters R, Evans WE (2005) Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia. Cancer Cell 7(4):375-386 (Pubitemid 40544654)
10. Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan GC, Pui CH, Grosveld G, Downing JR (1995) TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 9 (12):1985-1989 (Pubitemid 26023779)
11. Scurto P, Hsu Rocha M, Kane JR,Williams WK, Haney DM, Conn WP, Shurtleff SA, Downing JR (1998) A multiplex RT-PCR assay for the detection of chimeric transcripts encoded by the riskstratifying translocations of pediatric acute lymphoblastic leukemia. Leukemia 12(12):1994-2005 (Pubitemid 28554472)
12. Liang DC, Shih LY, Yang CP, Hung IJ, Chen SH, Jaing TH, Liu HC, Chang WH (2002) Multiplex RT-PCR assay for the detection of major fusion transcripts in Taiwanese children with B-lineage acute lymphoblastic leukemia. Med Pediatr Oncol 39(1):12-17
13. Poirel H, Oury C, Carron C, Duprez E, Laabi Y, Tsapis A, Romana SP, Mauchauffe M, Le Coniat M, Berger R, Ghysdael J, Bernard OA (1997) The TEL gene products: nuclear phosphoproteins with DNA binding properties. Oncogene 14(3):349-357 (Pubitemid 27073090)
14. Rompaey LV, Potter M, Adams C, Grosveld G (2000) Tel induces a G1 arrest and suppresses Ras-induced transformation. Oncogene 19(46):5244-5250
15. Golub TR, Barker GF, Lovett M, Gilliland DG (1994) Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77(2):307-316 (Pubitemid 24138627)
16. Bohlander SK (2005) ETV6: a versatile player in leukemogenesis. Semin Cancer Biol 15(3):162-174
17. Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA (1995) The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 85 (12):3662-3670
18. Liang DC, Chou TB, Chen JS, Shurtleff SA, Rubnitz JE, Downing JR, Pui CH, Shih LY (1996) High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan. Leukemia 10(6):991-993 (Pubitemid 26235932)
19. Romana SP, Poirel H, Leconiat M, Flexor MA, Mauchauffe M, Jonveaux P, Macintyre EA, Berger R, Bernard OA (1995) High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 86(11):4263-4269
20. Zuna J, Hrusak O, Kalinova M, Muzikova K, Stary J, Trka J (1999) Significantly lower relapse rate for TEL/AML1-positive ALL. Leukemia 13(10):1633 (Pubitemid 29465629)
21. Smith CA, Fan G (2008) The saga of JAK2 mutations and translocations in hematologic disorders: pathogenesis, diagnostic and therapeutic prospects, and revised World Health Organization diagnostic criteria for myeloproliferative neoplasms. Hum Pathol 39 (6):795-810 (Pubitemid 351758946)
22. Lacronique V, Boureux A, Valle VD, Poirel H, Quang CT, Mauchauffe M, Berthou C, Lessard M, Berger R, Ghysdael J, Bernard OA (1997) ATEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 278(5341):1309-1312 (Pubitemid 27495745)
23. Peeters P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P, Monpoux F, Van Rompaey L, BaensM, Van den Berghe H, Marynen P (1997) Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood 90(7):2535-2540 (Pubitemid 27413461)
24. La Starza R, Trubia M, Testoni N, Ottaviani E, Belloni E, Crescenzi B, Martelli M, Flandrin G, Pelicci PG, Mecucci C (2002) Clonal eosinophils are amorphologic hallmark of ETV6/ABL1 positive acute myeloid leukemia. Haematologica 87(8):789-794 (Pubitemid 34851547)
25. Zuna J, Zaliova M,Muzikova K, Meyer C, Lizcova L, Zemanova Z, Brezinova J, Votava F, Marschalek R, Stary J, Trka J (2010) Acute leukemias with ETV6/ABL1 (TEL/ABL) fusion: poor prognosis and prenatal origin. Genes Chromosomes Cancer 49(10):873-884
26. Nand R, Bryke C, Kroft SH, Divgi A, Bredeson C, Atallah E (2009) Myeloproliferative disorder with eosinophilia and ETV6- ABL gene rearrangement: efficacy of second-generation tyrosine kinase inhibitors. Leuk Res 33(8):1144-1146
27. Palmi C, Fazio G, Cassetti A, Aloisi A, Villa A, Biondi A, Cazzaniga G (2006) TEL/ARG induces cytoskeletal abnormalities in 293T cells. Cancer Lett 241(1):79-86
28. Cazzaniga G, Tosi S, Aloisi A, Giudici G, Daniotti M, Pioltelli P, Kearney L, Biondi A (1999) The tyrosine kinase abl-related gene ARG is fused to ETV6 in an AML-M4Eo patient with a t(1;12) (q25;p13): molecular cloning of both reciprocal transcripts. Blood 94(12):4370-4373
29. Gao N, Li ZH, Ding BT, Chen Y, Wang YS, Qiao Y, Guo NJ (2008) Expression of ETV6 rearrangement in a subject with acute myeloid leukemia-M4Eo. Chin Med J (Engl) 121(17):1744-1746
30. Voegel JJ, Heine MJ, Zechel C, Chambon P, Gronemeyer H (1996) TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 15 (14):3667-3675 (Pubitemid 26239779)
31. Strehl S, Nebral K, Konig M, Harbott J, Strobl H, Ratei R, Struski S, Bielorai B, Lessard M, Zimmermann M, Haas OA, Izraeli S (2008) ETV6-NCOA2: a novel fusion gene in acute leukemia associated with coexpression of T-lymphoid and myeloid markers and frequent NOTCH1 mutations. Clin Cancer Res 14(4):977-983 (Pubitemid 351302542)
32. Cazzaniga G, Daniotti M, Tosi S, Giudici G, Aloisi A, Pogliani E, Kearney L, Biondi A (2001) The paired box domain gene PAX5 is fused to ETV6/TEL in an acute lymphoblastic leukemia case. Cancer Res 61(12):4666-4670 (Pubitemid 32691872)
33. Coyaud E, Struski S, Prade N, Familiades J, Eichner R, Quelen C, Bousquet M, Mugneret F, Talmant P, Pages MP, Lefebvre C, Penther D, Lippert E, Nadal N, Taviaux S, Poppe B, Luquet I, Baranger L, Eclache V, Radford I, Barin C, Mozziconacci MJ, Lafage-Pochitaloff M, Antoine-Poirel H, Charrin C, Perot C, Terre C, Brousset P, Dastugue N, Broccardo C (2010) Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study. Blood 115(15):3089-3097
34. von Bergh AR, van Drunen E, van Wering ER, van Zutven LJ, Hainmann I, Lonnerholm G, Meijerink JP, Pieters R, Beverloo HB (2006) High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9. Genes Chromosomes Cancer 45(8):731-739
35. Taketani T, Taki T, Sako M, Ishii T, Yamaguchi S, Hayashi Y (2008) MNX1-ETV6 fusion gene in an acute megakaryoblastic leukemia and expression of the MNX1 gene in leukemia and normal B cell lines. Cancer Genet Cytogenet 186(2):115-119
36. Kuno Y (2001) Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12). Blood 97(4):1050-1055 (Pubitemid 32154292)
37. Zhou MH, Jiang MM, Gao L, Xu YY, Ding Y, Wang LL, Jing Y, Wang QS, Yu L (2011) Application of reverse transcriptionmultiplex nested PCR to detect PDGFRB gene rearrangement in myeloproliferative disorders. Zhongguo Shi Yan Xue Ye Xue Za Zhi 19(6):1443-1446
38. Felix CA, Lange BJ, Chessells JM (2000) Pediatric acute lymphoblastic leukemia: challenges and controversies in 2000. Hematology Am Soc Hematol Educ Program 285-302
39. Li ZG, Wu MY, Zhao W, Li B, Yang J, Zhu P, Hu YM (2003) Detection of 29 types of fusion gene in leukemia by multiplex RTPCR. Zhonghua Xue Ye Xue Za Zhi 24(5):256-258
40. Olesen LH, Clausen N, Dimitrijevic A, Kerndrup G, Kjeldsen E, Hokland P (2004) Prospective application of a multiplex reverse transcription-polymerase chain reaction assay for the detection of balanced translocations in leukaemia: a single-laboratory study of 390 paediatric and adult patients. Br J Haematol 127(1):59-66 (Pubitemid 39331107)
41. Magalhaes IQ, Pombo-de-Oliveira MS, Bennett CA, Cordoba JC, Dobbin J, Ford AM, Greaves MF (2000) TEL-AML1 fusion gene frequency in paediatric acute lymphoblastic leukaemia in Brazil. Br J Haematol 111(1):204-207
42. Sawinska M, Ladon D (2004) Mechanism, detection and clinical significance of the reciprocal translocation t(12;21)(p12;q22) in the children suffering from acute lymphoblastic leukaemia. Leuk Res 28(1):35-42 (Pubitemid 37433791)
43. Rubnitz JE, Wichlan D, Devidas M, Shuster J, Linda SB, Kurtzberg J, Bell B, Hunger SP, Chauvenet A, Pui CH, Camitta B, Pullen J (2008) Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. J Clin Oncol 26(13):2186-2191
44. Tirado CA, Chen W, Huang LJ, Laborde C, Hiemenz MC, Valdez F, Ho K, Winick N, Lou Z, Koduru P (2010) Novel JAK2 rearrangement resulting from a t(9;22)(p24;q11.2) in B-acute lymphoblastic leukemia. Leuk Res 34(12):1674-1676
45. Thai M, Ting PY, McLaughlin J, Cheng D, Muschen M, Witte ON, Colicelli J (2011) ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1. Leukemia 25(2):290-300
46. Barbouti A, Ahlgren T, Johansson B, Hoglund M, Lassen C, Turesson I, Mitelman F, Fioretos T (2003) Clinical and genetic studies of ETV6/ABL1-positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylate. Br J Haematol 122(1):85-93 (Pubitemid 36819342)
47. Kanie T, Abe A, Matsuda T, Kuno Y, Towatari M, Yamamoto T, Saito H, Emi N, Naoe T (2004) TEL-Syk fusion constitutively activates PI3-K/Akt, MAPK and JAK2-independent STAT5 signal pathways. Leukemia 18(3):548-555 (Pubitemid 38425870)
48. Okuda K, Sato Y, Sonoda Y, Griffin JD (2004) The TEL/ARG leukemia oncogene promotes viability and hyperresponsiveness to hematopoietic growth factors. Int J Hematol 79(2):138-146 (Pubitemid 38281813)